Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: SemiBull who wrote (1005)	9/18/2003 5:58:17 AM
From: SemiBull	Respond to of 1139

Levitra, a Rival With Ribald Ads, Gains on Viagra By GARDINER HARRIS "After one of the most expensive and ribald advertising blitzes in drug industry history, Levitra, the new impotence treatment, has in less than a month captured half of Viagra's market share among new prescriptions ... Just months away is another competitor, Cialis from Eli Lilly, which is under final review by the Food and Drug Administration. Cialis is effective for 36 hours while Viagra and Levitra work for four to five hours." nytimes.com